Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country
Abstract Whole genome sequencing (WGS) is revolutionary for diagnostics of TB and its mutations associated with drug-resistances, but its uptake in low- and middle-income countries is hindered by concerns of implementation feasibility. Here, we provide a proof of concept for its successful implement...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e5fcabad3dd49d4ae4aea89d3f6fd40 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3e5fcabad3dd49d4ae4aea89d3f6fd40 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3e5fcabad3dd49d4ae4aea89d3f6fd402021-12-02T16:31:02ZImplementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country10.1038/s41598-021-94297-z2045-2322https://doaj.org/article/3e5fcabad3dd49d4ae4aea89d3f6fd402021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94297-zhttps://doaj.org/toc/2045-2322Abstract Whole genome sequencing (WGS) is revolutionary for diagnostics of TB and its mutations associated with drug-resistances, but its uptake in low- and middle-income countries is hindered by concerns of implementation feasibility. Here, we provide a proof of concept for its successful implementation in such a setting. WGS was implemented in the Kyrgyz Republic. We estimated needs of up to 55 TB-WGS per week and chose the MiSeq platform (Illumina, USA) because of its capacity of up to 60 TB-WGS per week. The project’s timeline was completed in 93-weeks. Costs of large equipment and accompanying costs were 222,065 USD and 8462 USD, respectively. The first 174 WGS costed 277 USD per sequence, but this was skewed by training inefficiencies. Based on real prices and presuming optimal utilization of WGS capacities, WGS costs could drop to 167 and 141 USD per WGS using MiSeq Reagent Kits v2 (500-cycles) and v3 (600-cycles), respectively. Five trainings were required to prepare the staff for autonomous WGS which cost 48,250 USD. External assessment confirmed excellent performance of WGS by the Kyrgyz laboratory in an interlaboratory comparison of 30 M. tuberculosis genomes showing complete agreeance of results.Monica VogelChristian UtpatelCaroline CorbettThomas A. KohlAltyn IskakovaSevim AhmedovUladzimir AntonenkaViola DreyerAinura IbrahimovaChynara KamarliDilorom KosimovaVanessa MohrEvgeni SahalchykMeerim SydykovaNagira UmetalievaAbdylat KadyrovGulmira KalmambetovaStefan NiemannHarald HoffmannNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Monica Vogel Christian Utpatel Caroline Corbett Thomas A. Kohl Altyn Iskakova Sevim Ahmedov Uladzimir Antonenka Viola Dreyer Ainura Ibrahimova Chynara Kamarli Dilorom Kosimova Vanessa Mohr Evgeni Sahalchyk Meerim Sydykova Nagira Umetalieva Abdylat Kadyrov Gulmira Kalmambetova Stefan Niemann Harald Hoffmann Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country |
description |
Abstract Whole genome sequencing (WGS) is revolutionary for diagnostics of TB and its mutations associated with drug-resistances, but its uptake in low- and middle-income countries is hindered by concerns of implementation feasibility. Here, we provide a proof of concept for its successful implementation in such a setting. WGS was implemented in the Kyrgyz Republic. We estimated needs of up to 55 TB-WGS per week and chose the MiSeq platform (Illumina, USA) because of its capacity of up to 60 TB-WGS per week. The project’s timeline was completed in 93-weeks. Costs of large equipment and accompanying costs were 222,065 USD and 8462 USD, respectively. The first 174 WGS costed 277 USD per sequence, but this was skewed by training inefficiencies. Based on real prices and presuming optimal utilization of WGS capacities, WGS costs could drop to 167 and 141 USD per WGS using MiSeq Reagent Kits v2 (500-cycles) and v3 (600-cycles), respectively. Five trainings were required to prepare the staff for autonomous WGS which cost 48,250 USD. External assessment confirmed excellent performance of WGS by the Kyrgyz laboratory in an interlaboratory comparison of 30 M. tuberculosis genomes showing complete agreeance of results. |
format |
article |
author |
Monica Vogel Christian Utpatel Caroline Corbett Thomas A. Kohl Altyn Iskakova Sevim Ahmedov Uladzimir Antonenka Viola Dreyer Ainura Ibrahimova Chynara Kamarli Dilorom Kosimova Vanessa Mohr Evgeni Sahalchyk Meerim Sydykova Nagira Umetalieva Abdylat Kadyrov Gulmira Kalmambetova Stefan Niemann Harald Hoffmann |
author_facet |
Monica Vogel Christian Utpatel Caroline Corbett Thomas A. Kohl Altyn Iskakova Sevim Ahmedov Uladzimir Antonenka Viola Dreyer Ainura Ibrahimova Chynara Kamarli Dilorom Kosimova Vanessa Mohr Evgeni Sahalchyk Meerim Sydykova Nagira Umetalieva Abdylat Kadyrov Gulmira Kalmambetova Stefan Niemann Harald Hoffmann |
author_sort |
Monica Vogel |
title |
Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country |
title_short |
Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country |
title_full |
Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country |
title_fullStr |
Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country |
title_full_unstemmed |
Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country |
title_sort |
implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high mdr-tb burden country |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/3e5fcabad3dd49d4ae4aea89d3f6fd40 |
work_keys_str_mv |
AT monicavogel implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT christianutpatel implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT carolinecorbett implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT thomasakohl implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT altyniskakova implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT sevimahmedov implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT uladzimirantonenka implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT violadreyer implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT ainuraibrahimova implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT chynarakamarli implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT diloromkosimova implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT vanessamohr implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT evgenisahalchyk implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT meerimsydykova implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT nagiraumetalieva implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT abdylatkadyrov implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT gulmirakalmambetova implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT stefanniemann implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry AT haraldhoffmann implementationofwholegenomesequencingfortuberculosisdiagnosticsinalowmiddleincomehighmdrtbburdencountry |
_version_ |
1718383865529106432 |